Jiangsu Hengrui Medicine Co., Ltd. (HKG:1276)
Hong Kong · Delayed Price · Currency is HKD 75.20
+2.60 (3.58%)
At close: Oct 31, 2025
Jiangsu Hengrui Medicine Market Cap
Jiangsu Hengrui Medicine has a market cap or net worth of 465.52 billion as of October 31, 2025. Its market cap has increased by 26.38% in one year.
Market Cap
465.52B
Enterprise Value
421.98B
Revenue
33.86B
Ranking
n/a
PE Ratio
57.04
Stock Price
75.20
Market Cap Chart
Since October 20, 2000, Jiangsu Hengrui Medicine's market cap has increased from 2.43B to 465.52B, an increase of 19,080.36%. That is a compound annual growth rate of 23.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 465.52B | 49.88% |
| Dec 31, 2024 | 310.59B | -1.97% |
| Dec 29, 2023 | 316.84B | 14.05% |
| Dec 30, 2022 | 277.81B | -29.95% |
| Dec 31, 2021 | 396.57B | -43.57% |
| Dec 31, 2020 | 702.75B | 62.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.34B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 199.13B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 125.85B |
| Akeso | 105.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.36B |